uniQure Q2 FY26 net loss more than doubles to $81.06 million; revenue rises 9.5% to $5.84 million

PUBT · 3d ago
uniQure Q2 FY26 net loss more than doubles to $81.06 million; revenue rises 9.5% to $5.84 million
  • uniQure posted a GAAP net loss of USD 81.1 million, or USD 1.22 per share, in Q2 2026, widening from a year earlier.
  • Revenue rose 9.96% to USD 5.8 million, driven by higher license revenue.
  • R&D expenses fell 3.95% to USD 34 million, while SG&A expenses climbed 28.89% to USD 17.4 million.
  • Cash, cash equivalents and current investment securities totaled USD 810.3 million at June 30, 2026; a USD 259 million follow-on extended runway into 2030.
  • AMT-130 BLA submission for Huntington's disease remains on track for Q3 2026; topline four-year Phase I/II data expected September 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. uniQure NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607290705PRIMZONEFULLFEED9799628) on July 29, 2026, and is solely responsible for the information contained therein.